Cargando…
Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
BACKGROUND: The high lifetime risk of vascular disease is one of the important issues that plague patients with diabetes mellitus. Systemic oral vildagliptin administration favors endothelial recovery and inhibits smooth muscle cell (SMC) proliferation. However, the localized release of vildagliptin...
Autores principales: | Lee, Chen-Hung, Hsieh, Ming-Jer, Chang, Shang-Hung, Hung, Kuo-Chun, Wang, Chao-Jan, Hsu, Ming-Yi, Juang, Jyuhn-Huarng, Hsieh, I-Chang, Wen, Ming-Shien, Liu, Shih-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751553/ https://www.ncbi.nlm.nih.gov/pubmed/31686818 http://dx.doi.org/10.2147/IJN.S211898 |
Ejemplares similares
-
Promoting vascular healing using nanofibrous ticagrelor-eluting stents
por: Lee, Cheng-Hung, et al.
Publicado: (2018) -
Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
Publicado: (2019) -
Nanofibrous insulin/vildagliptin core-shell PLGA scaffold promotes diabetic wound healing
por: Lee, Chen-Hung, et al.
Publicado: (2023) -
Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents
por: Lee, Cheng-Hung, et al.
Publicado: (2014) -
Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Lee, Cheng-Hung, et al.
Publicado: (2017)